Provista Diagnostics Accepted for a Late-Breaking Data Presentation at the 2014 San Antonio Breast Cancer Symposium
10 nov. 2014 09h51 HE
|
Provista Diagnostics, Inc.
NEW YORK, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing a new generation of proprietary...
Provista Diagnostics to Present at Rodman & Renshaw Annual Global Investment Conference
09 sept. 2014 08h54 HE
|
Provista Diagnostics, Inc.
NEW YORK, Sept. 9, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing proprietary blood-based diagnostic,...
Provista Diagnostics Announces Key Data Presented at the American Society of Clinical Oncologist Breast 2014 Annual Meeting
08 sept. 2014 13h42 HE
|
Provista Diagnostics, Inc.
NEW YORK, Sept. 8, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing proprietary blood-based diagnostic,...
Provista Diagnostics Completes Enrollment of its 001 Prospective Study of Protein-Based Biomarker Blood Test to Aid in Detection of Breast Cancer
15 juil. 2014 05h00 HE
|
Provista Diagnostics, Inc.
New York, NY, July 15, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a personalized medicine company
focused on developing and commercializing proprietary blood-based
prognostic, diagnostic,...
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
07 juil. 2014 05h00 HE
|
Provista Diagnostics, Inc.
New York, NY, July 7, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...
Provista Diagnostics Laboratory Receives Accreditation from College of American Pathologists (CAP)
26 juin 2014 05h00 HE
|
Provista Diagnostics, Inc.
New York, NY, June 26, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
delivering precision medicine to the medical community to
fundamentally change the detection...
Provista Diagnostics Expands Exclusive License Agreement for Biomarker Technologies Developed at the Biodesign Institute at Arizona State University
28 mai 2014 05h00 HE
|
Provista Diagnostics, Inc.
NEW YORK, NY, May 28, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...
Provista Diagnostics Announces First Patient Enrolled in Prospective, Proof-of-Concept Study of its Protein Biomarker Blood Test to Assess the Presence of Breast Cancer
19 mai 2014 05h00 HE
|
Provista Diagnostics, Inc.
New York, NY, May 19, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...
Provista Diagnostics Secures $6MM Series B Financing
16 avr. 2014 05h00 HE
|
Provista Diagnostics, Inc.
Scottsdale, Arizona, April 16, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately held molecular
diagnostics company developing and commercializing diagnostic,
prognostic and predictive...
Provista Diagnostics Licenses Biomarker Technologies Developed at Arizona State University
25 oct. 2013 05h00 HE
|
Provista Diagnostics, Inc.
Scottsdale, Arizona, Oct. 25, 2013 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a leading molecular diagnostics
company focused on developing and commercializing proprietary
diagnostic, prognostic...